A recent decision of the UK High Court illustrates reasons why it is often preferable to register your designs rather than relying on unregistered design protection alone.

As part of the fallout from the recent G1/19 decision, the Guidelines for Examination in the EPO will have to be updated to reflect the new law.

June is Pride month – an annual celebration of, and support for, the lesbian, gay, bisexual, transgender and queer communities (often shortened to "LGBTQ").

The electric vehicle (EV) market is rapidly picking up pace.

This is the second in a series of articles exploring how intellectual property (IP), and in particular patents, can support growth of your business.

Of course, they won't come out and say it, but the answer to our mind is undoubtedly yes – whether that was on purpose or not, only the EPO will know.

The development of Augmented Reality (AR) assisted surgical techniques is moving rapidly, with GlobalData predicting the next 10 years will see the AR market in health care reach $76...

On 15 February the USPTO announced its long-awaited decision regarding the CRISPR patent interference proceedings between the University of California Berkley (UCB) and the Broad Institute of MIT.

The lure and potential of China to food and drink manufacturers is obvious. China has a burgeoning middle class with an ever-increasing disposable income and Western brands are highly regarded...

The UK's National Food Crime Unit recently estimated that piracy could account for more than one billion pounds of annual UK food and drink trade.

This is the third in a series of three articles prepared for the Intelligent Health community, directed at all innovators using artificial intelligence to solve problems in healthcare.

Patents directed to a polymorph can be an effective way to obtain second- or third-line protection for lead drug candidates.

The European Patent Office has recently confirmed that computer simulations can be patentable. However, whether or not a simulation is likely to be patentable isn't always straightforward.

This is the second in a series of three articles prepared for the Intelligent Health community, directed at all innovators using artificial intelligence to solve problems in healthcare.

This is the first of a series of articles prepared for the Intelligent Health community, directed at all innovators using artificial intelligence to solve problems in healthcare.

It is just over four years since Board 3.3.01 of the EPO Boards of Appeal delivered its much-anticipated decision in the Dasatinib case (T 488/16).

The EPO's Enlarged Board of appeal handed down decision G1/19 on 10 March 2021. This decision concerns the patentability of computer simulations under the European Patent Convention (EPC).

"If this business were to split up, I would be glad to take the brands, trade marks and goodwill and you could have all the bricks and mortar – and I would fare better than you."

Machine learning and artificial intelligence have gained an explosion of attention in recent years as a tool that can be deployed against a wide variety of problems.